These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9702495)

  • 21. Detection of Her-2/neu oncogene in breast carcinoma by chromogenic in situ hybridization in cytologic specimens.
    Lin F; Shen T; Prichard JW
    Diagn Cytopathol; 2005 Dec; 33(6):376-80. PubMed ID: 16299744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of primed in situ labelling in determination of HER-2 gene amplification and CEN-17 status in breast cancer tissue.
    Salimi M; Mozdarani H; Majidzadeh-A K
    Asian Pac J Cancer Prev; 2012; 13(1):329-37. PubMed ID: 22502695
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estimation of estrogen receptor content in fine-needle aspirates from breast cancer using the monoclonal antibody 1D5 and microwave oven processing: correlation with paraffin embedded and frozen sections determinations.
    Schmitt FC; Bento MJ; Amendoeira I
    Diagn Cytopathol; 1995 Nov; 13(4):347-51. PubMed ID: 8599924
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of fine-needle aspiration to the demonstration of ERBB2 and MYC expression by in situ hybridization in breast carcinoma.
    Soini Y; Mannermaa A; Winqvist R; Kamel D; Poikonen K; Kiviniemi H; Pääkkö P
    J Histochem Cytochem; 1994 Jun; 42(6):795-803. PubMed ID: 7910618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of HER-2 status determined by fluorescence in situ hybridization in primary and metastatic breast carcinoma.
    Gong Y; Booser DJ; Sneige N
    Cancer; 2005 May; 103(9):1763-9. PubMed ID: 15786420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chromosome in situ hybridization on formalin-fixed mammary tissue using non-isotopic, non-fluorescent probes: technical considerations and biological implications.
    Dhingra K; Sahin A; Supak J; Kim SY; Hortobagyi G; Hittelman WN
    Breast Cancer Res Treat; 1992; 23(3):201-10. PubMed ID: 1463859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fluorescence in situ hybridization for HER-2/neu amplification of breast carcinoma in archival fine needle aspiration biopsy specimens.
    Gu M; Ghafari S; Zhao M
    Acta Cytol; 2005; 49(5):471-6. PubMed ID: 16334021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinicopathologic analysis of breast carcinoma with chromosomal aneusomy detected by fluorescence in situ hybridization.
    Tsukamoto F; Miyoshi Y; Egawa C; Kasugai T; Takami S; Inazawa J; Noguchi S
    Cancer; 2001 Apr; 93(2):165-70. PubMed ID: 11309784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ploidy analysis by in situ hybridization of interphase cell nuclei in fine-needle aspirates from breast carcinomas: correlation with cytologic grading.
    Sauer T; Beraki K; Jebsen PW; Ormerod E; Naess O
    Diagn Cytopathol; 1997 Oct; 17(4):267-71. PubMed ID: 9316782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [HER-2 oncogene amplification assessment in invasive breast cancer by dual-color in situ hybridization (dc-CISH): a comparative study with fluorescent in situ hybridization (FISH)].
    Akhdar A; Bronsard M; Lemieux R; Geha S
    Ann Pathol; 2011 Dec; 31(6):472-9. PubMed ID: 22172120
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Numerical aberrations of chromosomes 1 and 7 by fluorescent in situ hybridization and DNA ploidy analysis in breast cancer.
    Kapranos N; Kounelis S; Karantasis H; Kouri E
    Breast J; 2005; 11(6):448-53. PubMed ID: 16297090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Detection of numerical aberrations in chromosomes by fluorescence in situ hybridization in fine needle aspirates in the preoperative diagnosis of cancer].
    Noguchi S; Tsukamoto F; Miyoshi Y; Inaji H; Watatani M; Sasa M; Inazawa J; Takami S
    Gan To Kagaku Ryoho; 1999 Dec; 26(14):2127-30. PubMed ID: 10635294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of Her-2/Neu status in breast carcinoma: comparative analysis of immunohistochemistry and fluorescent in situ hybridization.
    Jimenez RE; Wallis T; Tabasczka P; Visscher DW
    Mod Pathol; 2000 Jan; 13(1):37-45. PubMed ID: 10658908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chromogenic in situ hybridization to detect HER-2/neu gene amplification in histological and ThinPrep-processed breast cancer fine-needle aspirates: a sensitive and practical method in the trastuzumab era.
    Vocaturo A; Novelli F; Benevolo M; Piperno G; Marandino F; Cianciulli AM; Merola R; Donnorso RP; Sperduti I; Buglioni S; Mottolese M
    Oncologist; 2006 Sep; 11(8):878-86. PubMed ID: 16951391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chromogenic in situ hybridization analysis of HER-2/neu status in cytological samples of breast carcinoma.
    Kim GY; Oh YL
    Cytopathology; 2004 Dec; 15(6):315-20. PubMed ID: 15606364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Assessment and significance of human epidermal growth factor receptor 2 gene status in breast cancer with polysomy of chromosome 17].
    Zhang H; Si JW; Zhang S; Wang Y; Li D; Li T
    Zhonghua Zhong Liu Za Zhi; 2016 Feb; 38(2):124-9. PubMed ID: 26899332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chromosomal aneusomy (chr 1, 11, 17) detected by fluorescence in situ hybridization may be a prognostic factor in breast cancer.
    Takehisa M; Sasa M; Bando Y; Hirose T; Morimoto T; Nagao T; Tangoku A
    Anticancer Res; 2007; 27(2):1073-8. PubMed ID: 17465246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determining true HER2 gene status in breast cancers with polysomy by using alternative chromosome 17 reference genes: implications for anti-HER2 targeted therapy.
    Tse CH; Hwang HC; Goldstein LC; Kandalaft PL; Wiley JC; Kussick SJ; Gown AM
    J Clin Oncol; 2011 Nov; 29(31):4168-74. PubMed ID: 21947821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of human epidermal growth factor receptor 2 protein and gene in fine needle aspiration cytology specimens and tissue sections from invasive breast cancer: can cytology specimens take the place of tissue sections?
    Sumiyoshi K; Shibayama Y; Akashi S; Nohara T; Iwamoto M; Kobayashi T; Nishimura H; Yoshinaka R; Harada T; Tanigawa N
    Oncol Rep; 2006 Apr; 15(4):803-8. PubMed ID: 16525662
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Detection of numerical chromosome aberrations in human sperm nuclei using in situ hybridization from formarin-fixed clot sections].
    Nemoto R; Sanematsu H
    Nihon Hinyokika Gakkai Zasshi; 1994 Jul; 85(7):1079-83. PubMed ID: 8078224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.